Kuanxiong Aerosol () in Treatment of Angina Pectoris: A Literature Review and Network Pharmacology.
10.1007/s11655-021-2867-y
- Author:
Yu-Zhuo ZHANG
1
;
Rui-Xiang ZENG
1
;
Yuan-Shen ZHOU
2
;
Min-Zhou ZHANG
3
Author Information
1. The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.
2. Department of Critical Care Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.
3. The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510120, China. minzhouzhang@aliyun.com.
- Publication Type:Review
- Keywords:
Kuanxiong Aerosol;
angina pectoris;
clinical application;
network pharmacology;
pharmacology
- From:
Chinese journal of integrative medicine
2021;27(6):470-480
- CountryChina
- Language:English
-
Abstract:
Angina pectoris (AP) is the most common symptom of cardiovascular diseases, which seriously affects the quality of life in cardiovascular patients. Kuanxiong (KX) Aerosol (), a compound preparation that consists of 5 traditional Chinese medicines: Herba Asari , Rhizoma Alpiniae Officinarum, Lignum Santali Albi, Fructus Piperis Longi, and Borneolum, has been used in the treatment of AP for many years, exhibiting a significant curative effect and less side-effect. For the convenience and comprehensive understanding of KX Aerosol, this review systematically summarizes evidence on KX Aerosol in the treatment of AP including the pharmacological effects of its composition, clinical research, animal experiments, and network pharmacology prediction. Meanwhile, we highlight the research limitation of KX Aerosol at present. This review may guide the clinical application of KX Aerosol and further provide a reference for the research of AP.
